Cargando…

Progression-Free Survival Prediction in Small Cell Lung Cancer Based on Radiomics Analysis of Contrast-Enhanced CT

PURPOSES AND OBJECTIVES: The aim of this study was to predict the progression-free survival (PFS) in patients with small cell lung cancer (SCLC) by radiomic signature from the contrast-enhanced computed tomography (CT). METHODS: A total of 186 cases with pathological confirmed small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ningxin, Li, Ruikun, Jiang, Mengmeng, Guo, Yixian, Chen, Jiejun, Sun, Dazhen, Wang, Lisheng, Yao, Xiuzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911879/ https://www.ncbi.nlm.nih.gov/pubmed/35280863 http://dx.doi.org/10.3389/fmed.2022.833283

Ejemplares similares

CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yan, Chang, et al.
Publicado: (2021)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma
por: Li, Wen-zhu, et al.
Publicado: (2022)

Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
por: Chen, Wen, et al.
Publicado: (2021)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Non-contrast and contrast enhanced computed tomography radiomics in preoperative discrimination of lung invasive and non-invasive adenocarcinoma
por: Sun, Yingli, et al.
Publicado: (2022)

Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer
por: Li, Junmeng, et al.
Publicado: (2020)

Non-Contrasted CT Radiomics for SAH Prognosis Prediction
por: Shan, Dezhi, et al.
Publicado: (2023)

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
por: Yan, Lei, et al.
Publicado: (2021)

CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer
por: Wan, Sheng, et al.
Publicado: (2023)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
por: Chang, Runsheng, et al.
Publicado: (2023)

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols
por: Budai, Bettina Katalin, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Development and Validation of a Nomogram Based on (18)F-FDG PET/CT Radiomics to Predict the Overall Survival in Adult Hemophagocytic Lymphohistiocytosis
por: Yang, Xu, et al.
Publicado: (2021)

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2023)

Habitat radiomics analysis of pet/ct imaging in high-grade serous ovarian cancer: Application to Ki-67 status and progression-free survival
por: Wang, Xinghao, et al.
Publicado: (2022)

Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma
por: Zhang, Haijie, et al.
Publicado: (2022)

Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
por: De Bari, Berardino, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review
por: Yan, Gaowu, et al.
Publicado: (2022)

Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients—a radiomics nomogram analysis
por: Yang, Xiaoyan, et al.
Publicado: (2021)

Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey
por: Annunziata, Salvatore, et al.
Publicado: (2023)

CT-based radiomic phenotypes of lung adenocarcinoma: a preliminary comparative analysis with targeted next-generation sequencing
por: Liu, Xiaowen, et al.
Publicado: (2023)

(68)Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
por: Liberini, Virginia, et al.
Publicado: (2021)

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma
por: Cen, Chunyuan, et al.
Publicado: (2023)

Identifying ureteral stent encrustation using machine learning based on CT radiomics features: a bicentric study
por: Qiu, Junliang, et al.
Publicado: (2023)

CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset
por: Avesani, Giacomo, et al.
Publicado: (2022)

CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients
por: Meng, Dongxiao, et al.
Publicado: (2021)

Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures
por: Cui, Yongbin, et al.
Publicado: (2022)

Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker
por: Wang, Jincheng, et al.
Publicado: (2022)

Radiomics Analysis of PET and CT Components of (18)F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
por: Wang, Xihai, et al.
Publicado: (2021)

Radiomics-based aortic flow profile characterization with 4D phase-contrast MRI
por: Huellebrand, Markus, et al.
Publicado: (2023)

Mammography radiomics features at diagnosis and progression-free survival among patients with breast cancer
por: Luo, Chuanxu, et al.
Publicado: (2022)

Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma
por: Zhou, Yue, et al.
Publicado: (2023)

Dextran-based Nanomicelle System with Directly Ester-bound Gadolinium Chelates as a Magnetic Resonance Imaging Contrast Agent for Tumor Detection
por: Ma, Lirong, et al.
Publicado: (2020)

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
por: Xu, Tingfeng, et al.
Publicado: (2022)

Prediction of Overall Survival and Progression-Free Survival by the (18)F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
por: Zhou, Yi, et al.
Publicado: (2019)

Radiomics and Machine Learning for Detecting Scar Tissue on CT Delayed Enhancement Imaging
por: O'Brien, Hugh, et al.
Publicado: (2022)

Pericoronary radiomics texture features associated with hypercholesterolemia on a photon-counting-CT
por: Kahmann, Jannik, et al.
Publicado: (2023)

Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study
por: Li, Ke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c15r729cc2t38pu4unbn4vr6k0